Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A10033 | 31518646 | J Hepatol | A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe. | 2019 | Details |
| A10035 | 31518478 | Liver Transpl | Delayed Sleeve Gastrectomy Following Liver Transplantation: A 5-Year Experience. | 2019 | Details |
| A10036 | 31517837 | Medicine (Baltimore) | Obesity and nonalcoholic fatty liver disease associated with adenocarcinoma in patients with lung cancer. | 2019 | Details |
| A10041 | 31516268 | J Clin Exp Hepatol | Drug Development for Nonalcoholic Fatty Liver Disease: Landscape and Challenges. | 2019 | Details |
| A10042 | 31516267 | J Clin Exp Hepatol | Screening of Cardiovascular Disease in Nonalcoholic Fatty Liver Disease: Whom and How? | 2019 | Details |
| A10043 | 31516266 | J Clin Exp Hepatol | Magnitude of Nonalcoholic Fatty Liver Disease: Western Perspective. | 2019 | Details |
| A10044 | 31516265 | J Clin Exp Hepatol | Magnitude of Nonalcoholic Fatty Liver Disease: Eastern Perspective. | 2019 | Details |
| A10045 | 31515740 | Hepatol Int | Significant decrease in Faecalibacterium among gut microbiota in nonalcoholic fatty liver disease: a large BMI- and sex-matched population study. | 2019 | Details |
| A10046 | 31514755 | BMC Pediatr | Increased liver echogenicity and liver enzymes are associated with extreme obesity, adolescent age and male gender: analysis from the German/Austrian/Swiss obesity registry APV. | 2019 | Details |
| A10048 | 31514105 | Cytokine | Increased plasma osteopontin levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. | 2019 | Details |
| A10051 | 31512431 | Adv Gerontol | [The effect of high-dose metformin on the metabolic parameters and functional state of the liver of agouti-mice with the melanocortin obesity.] | 2019 | Details |
| A10056 | 31506976 | Hepatology | Vitamin D Receptor Activation in Liver Macrophages Ameliorates Hepatic Inflammation, Steatosis, and Insulin Resistance in Mice. | 2020 | Details |
| A10059 | 31505904 | Int J Mol Sci | Nonalcoholic Fatty Liver Disease (NAFLD), But not Its Susceptibility Gene Variants, Influences the Decrease of Kidney Function in Overweight/Obese Children. | 2019 | Details |
| A10062 | 31505462 | J Endocrinol | Mice lacking adenosine 2A receptor reveal increased severity of MCD-induced NASH. | 2019 | Details |
| A10063 | 31505325 | Redox Biol | Peroxiredoxin 5 ameliorates obesity-induced non-alcoholic fatty liver disease through the regulation of oxidative stress and AMP-activated protein kinase signaling. | 2019 | Details |
| A10066 | 31504822 | Nutr Rev | Role of fruit juice in achieving the 5-a-day recommendation for fruit and vegetable intake. | 2019 | Details |
| A10067 | 31504710 | J Nutr | Food Insecurity May Be an Independent Risk Factor Associated with Nonalcoholic Fatty Liver Disease among Low-Income Adults in the United States. | 2020 | Details |
| A10074 | 31500354 | Cells | Melatonin Effects on Non-Alcoholic Fatty Liver Disease Are Related to MicroRNA-34a-5p/Sirt1 Axis and Autophagy. | 2019 | Details |
| A10076 | 31497874 | Br J Pharmacol | Delayed intervention with a novel SGLT2 inhibitor NGI001 suppresses diet-induced metabolic dysfunction and non-alcoholic fatty liver disease in mice. | 2019 | Details |
| A10078 | 31497742 | Hepatol Commun | Interleukin-32 Contributes to Human Nonalcoholic Fatty Liver Disease and Insulin Resistance. | 2019 | Details |
| A10080 | 31496904 | J Med Biochem | Predictive Values of Serum Uric Acid and Alanine-aminotransferase for Fatty Liver Index in Montenegrin Population. | 2019 | Details |
| A10085 | 31493478 | Life Sci | Strength training reduces lipid accumulation in liver of obese Wistar rats. | 2019 | Details |
| A10090 | 31491949 | Int J Mol Sci | Combined Treatment with L-Carnitine and Nicotinamide Riboside Improves Hepatic Metabolism and Attenuates Obesity and Liver Steatosis. | 2019 | Details |
| A10092 | 31491513 | Int J Biol Macromol | MDG-1, an Ophiopogon polysaccharide, restrains process of non-alcoholic fatty liver disease via modulating the gut-liver axis. | 2019 | Details |
| A10098 | 31485221 | Int J Endocrinol | Compound C Protects Mice from HFD-Induced Obesity and Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10100 | 31484207 | J Periodontol | Association between periodontal status and non-alcoholic fatty liver disease in a Korean adult population: A nationwide cross-sectional study. | 2019 | Details |
| A10103 | 31483669 | J Proteome Res | High Throughput Screening of Serum γ-Glutamyl Dipeptides for Risk Assessment of Nonalcoholic Steatohepatitis with Impaired Glutathione Salvage Pathway. | 2019 | Details |
| A10106 | 31482741 | Arch Physiol Biochem | Low level of adiponectin predicts the development of Nonalcoholic fatty liver disease: is it irrespective to visceral adiposity index, visceral adipose tissue thickness and other obesity indices? | 2019 | Details |
| A10107 | 31482482 | Obes Surg | Safety and Utility of Liver Biopsy During Bariatric Surgery in the New Zealand Setting. | 2020 | Details |
| A10112 | 31479282 | Expert Opin Drug Saf | The safety of anti-interleukins monoclonal antibodies for the treatment of psoriasis. | 2019 | Details |
| A10115 | 31477174 | Stem Cell Res Ther | Antioxidant-upregulated mesenchymal stem cells reduce inflammation and improve fatty liver disease in diet-induced obesity. | 2019 | Details |
| A10116 | 31477078 | BMC Endocr Disord | Cholecystectomy versus central obesity or insulin resistance in relation to the risk of nonalcoholic fatty liver disease: the third US National Health and Nutrition Examination Survey. | 2019 | Details |
| A10125 | 31474632 | Yakugaku Zasshi | [Role of Angiogenesis and Chronic Inflammation in Fat Hypertrophy in NASH Pathology]. | 2019 | Details |
| A10130 | 31473746 | Dig Dis | Increased Prevalence of Colorectal Adenomas in Patients with Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study. | 2019 | Details |
| A10133 | 31472960 | Biochem Biophys Res Commun | Knockout of neutrophil elastase protects against western diet induced nonalcoholic steatohepatitis in mice by regulating hepatic ceramides metabolism. | 2019 | Details |
| A10134 | 31472955 | Biochem Biophys Res Commun | Vitexin alleviates non-alcoholic fatty liver disease by activating AMPK in high fat diet fed mice. | 2019 | Details |
| A10136 | 31471434 | BMJ Open | The association between a non-invasive hepatic fibrosis score and urolithiasis among non-alcoholic fatty liver disease (NAFLD) patients in China: a cross-sectional study. | 2019 | Details |
| A10143 | 31470414 | Endocr Connect | Insulin resistance associates with hepatic lobular inflammation in subjects with obesity. | 2019 | Details |
| A10145 | 31470247 | J Trace Elem Med Biol | Aluminium levels in hair and urine are associated with overweight and obesity in a non-occupationally exposed population. | 2019 | Details |
| A10146 | 31470068 | J Hepatol | The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study. | 2019 | Details |
| A10149 | 31469122 | Pol Arch Intern Med | Serum pentraxin 3 concentration in patients with type 2 diabetes and nonalcoholic fatty liver disease. | 2019 | Details |
| A10150 | 31467918 | Biomed Res Int | Abdominal Obesity as a Predictive Factor of Nonalcoholic Fatty Liver Disease Assessed by Ultrasonography and Transient Elastography in Polycystic Ovary Syndrome and Healthy Women. | 2019 | Details |
| A10154 | 31466361 | Int J Environ Res Public Health | Chemical Effect of Bisphenol A on Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A10155 | 31465774 | Biochem Pharmacol | Functions of aryl hydrocarbon receptor (AHR) and CD38 in NAD metabolism and nonalcoholic steatohepatitis (NASH). | 2019 | Details |
| A10160 | 31464779 | Eur J Gastroenterol Hepatol | Performance of noninvasive scores for the diagnosis of advanced liver fibrosis in morbidly obese with nonalcoholic fatty liver disease. | 2020 | Details |
| A10169 | 31456946 | Front Oncol | Recent Insights Into the Multiple Pathways Driving Non-alcoholic Steatohepatitis-Derived Hepatocellular Carcinoma. | 2019 | Details |
| A10171 | 31455870 | Int J Obes (Lond) | Specific diacylglycerols generated by hepatic lipogenesis stimulate the oncogenic androgen receptor activity in male hepatocytes. | 2019 | Details |
| A10172 | 31455011 | Int J Environ Res Public Health | Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications. | 2019 | Details |
| A10174 | 31454158 | Mol Nutr Food Res | Tomatidine Reduces Palmitate-Induced Lipid Accumulation by Activating AMPK via Vitamin D Receptor-Mediated Signaling in Human HepG2 Hepatocytes. | 2019 | Details |
| A10179 | 31447675 | Front Pharmacol | NAFLD and Diabetes: Two Sides of the Same Coin? Rationale for Gene-Based Personalized NAFLD Treatment. | 2019 | Details |
| A10180 | 31447605 | Malays J Med Sci | The 2017 M Balasegaram Memorial Lecture: The Changing Landscape of Liver Diseases in Malaysia-60 Years On! | 2019 | Details |
| A10182 | 31446562 | Obes Surg | Intraoperative Liver Biopsy During Adolescent Bariatric Surgery: Is It Really Necessary? | 2020 | Details |
| A10194 | 31439237 | Eur J Radiol | Quantification of steatosis in alcoholic and nonalcoholic fatty liver disease: Evaluation of four MR techniques versus biopsy. | 2019 | Details |
| A10197 | 31438482 | Int J Environ Res Public Health | Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way. | 2019 | Details |
| A10209 | 31431413 | HPB (Oxford) | Non-alcoholic fatty liver disease after liver transplantation in patients with non-alcoholic steatohepatitis and cryptogenic cirrhosis: the impact of pre-transplant graft steatosis. | 2019 | Details |
| A10210 | 31430977 | Int J Mol Sci | Paraoxonase-1 as a Regulator of Glucose and Lipid Homeostasis: Impact on the Onset and Progression of Metabolic Disorders. | 2019 | Details |
| A10216 | 31428204 | Diabetol Metab Syndr | Incidence and risk factors for metabolic syndrome among urban, adult Sri Lankans: a prospective, 7-year community cohort, follow-up study. | 2019 | Details |
| A10217 | 31428049 | Front Endocrinol (Lausanne) | The Liver in Children With Metabolic Syndrome. | 2019 | Details |
| A10220 | 31425956 | Diabetes Metab Syndr | A review of synbiotic efficacy in non-alcoholic fatty liver disease as a therapeutic approach. | 2019 | Details |
| A10221 | 31423319 | BMJ Open Gastroenterol | High potency multistrain probiotic improves liver histology in non-alcoholic fatty liver disease (NAFLD): a randomised, double-blind, proof of concept study. | 2019 | Details |
| A10223 | 31422074 | Arch Biochem Biophys | CRISPR Cas9-mediated deletion of biliverdin reductase A (BVRA) in mouse liver cells induces oxidative stress and lipid accumulation. | 2019 | Details |
| A10224 | 31422063 | Lancet Diabetes Endocrinol | Metabolic health in the Middle East and north Africa. | 2019 | Details |
| A10228 | 31421090 | Eur J Pharmacol | Iron chelators in obesity therapy - Old drugs from a new perspective? | 2019 | Details |
| A10229 | 31420528 | J Pharmacol Exp Ther | Withaferin A Improves Nonalcoholic Steatohepatitis in Mice. | 2019 | Details |
| A10235 | 31419414 | Clin Chim Acta | Fibroblast growth factor 21 in lipid metabolism and non-alcoholic fatty liver disease. | 2019 | Details |
| A10238 | 31418344 | Curr Vasc Pharmacol | What Does the Future Hold for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis? | 2019 | Details |
| A10240 | 31415794 | Mol Cell Endocrinol | Creosote bush-derived NDGA attenuates molecular and pathological changes in a novel mouse model of non-alcoholic steatohepatitis (NASH). | 2019 | Details |
| A10246 | 31413522 | World J Gastroenterol | Hepatocellular carcinoma and metabolic syndrome: The times are changing and so should we. | 2019 | Details |
| A10247 | 31413241 | J Oleo Sci | Elaeagnus mollis Oil Attenuates Non-alcoholic Fatty Disease in High-fat Diet Induced Obese Mice via Modifying the Expression of Lipid Metabolismrelated Genes. | 2019 | Details |
| A10248 | 31412686 | Genes (Basel) | Transcriptomic Analysis of Porcine Granulosa Cells Overexpressing Retinol Binding Protein 4. | 2019 | Details |
| A10249 | 31412267 | Eur J Pharmacol | Liraglutide improves insulin sensitivity in high fat diet induced diabetic mice through multiple pathways. | 2019 | Details |
| A10253 | 31410151 | Exp Ther Med | Association between abdominal obesity and liver steatosis and fibrosis among patients with chronic hepatitis B measured by Fibroscan. | 2019 | Details |
| A10257 | 31408914 | Mol Nutr Food Res | In Utero One-Carbon Metabolism Interplay and Metabolic Syndrome in Cardiovascular Disease Risk Reduction. | 2019 | Details |
| A10258 | 31408586 | Mol Nutr Food Res | Lycopene Alleviates Obesity-Induced Inflammation and Insulin Resistance by Regulating M1/M2 Status of Macrophages. | 2019 | Details |
| A10259 | 31408567 | Hepatol Res | Identification of two microRNA nodes as potential cooperative modulators of liver metabolism. | 2019 | Details |
| A10260 | 31408437 | J Clin Invest | Nuclear envelope-localized torsinA-LAP1 complex regulates hepatic VLDL secretion and steatosis. | 2019 | Details |
| A10262 | 31408176 | J Clin Endocrinol Metab | Hepatic Fatty Acid Balance and Hepatic Fat Content in Humans With Severe Obesity. | 2019 | Details |
| A10270 | 31405127 | Nutrients | Sex-Specific Differences in Fat Storage, Development of Non-Alcoholic Fatty Liver Disease and Brain Structure in Juvenile HFD-Induced Obese Ldlr-/-.Leiden Mice. | 2019 | Details |
| A10271 | 31404666 | Clin Gastroenterol Hepatol | Increasing Liver Fat Is Associated With Incident Cardiovascular Risk Factors. | 2019 | Details |
| A10281 | 31401193 | EBioMedicine | Simulation of gastric bypass effects on glucose metabolism and non-alcoholic fatty liver disease with the Sleeveballoon device. | 2019 | Details |
| A10283 | 31400075 | Kaohsiung J Med Sci | The relationship between nonalcoholic fatty liver disease and pediatric congenital hypothyroidism patients. | 2019 | Details |
| A10285 | 31399173 | Transplant Proc | Range of Normal Serum Aminotransferase Levels in Liver Transplant Recipients. | 2019 | Details |
| A10287 | 31399032 | Lipids Health Dis | Correlation of triglyceride to high-density lipoprotein cholesterol ratio with nonalcoholic fatty liver disease among the non-obese Chinese population with normal blood lipid levels: a retrospective cohort research. | 2019 | Details |
| A10294 | 31396337 | Am J Transl Res | Swimming prevents nonalcoholic fatty liver disease by reducing migration inhibitory factor through Akt suppression and autophagy activation. | 2019 | Details |
| A10295 | 31394881 | Nutrients | Non-Alcoholic Fatty Liver Disease is Associated with Higher Metabolic Expenditure in Overweight and Obese Subjects: A Case-Control Study. | 2019 | Details |
| A10299 | 31393851 | J Clin Invest | Degradation of splicing factor SRSF3 contributes to progressive liver disease. | 2019 | Details |
| A10308 | 31391339 | JCI Insight | The hepatokine Tsukushi is released in response to NAFLD and impacts cholesterol homeostasis. | 2019 | Details |
| A10309 | 31390852 | Turk J Med Sci | Association between PPARGC1A single nucleotide polymorphisms and increased risk of nonalcoholic fatty liver disease among Iranian patients with type 2 diabetes mellitus | 2019 | Details |
| A10311 | 31390281 | J Med Food | Elucidation of the Metabolic and Transcriptional Responses of an Oriental Herbal Medicine, Bangpungtongseong-san, to Nonalcoholic Fatty Liver Disease in Diet-Induced Obese Mice. | 2019 | Details |
| A10315 | 31389294 | Epigenetics | Non-alcoholic fatty liver disease (NAFLD) is associated with dynamic changes in DNA hydroxymethylation. | 2019 | Details |
| A10321 | 31388624 | Hepatol Commun | Genetic Polymorphisms Implicated in Nonalcoholic Liver Disease or Selected Other Disorders Have No Influence on Drug-Induced Liver Injury. | 2019 | Details |
| A10322 | 31388398 | World J Hepatol | Rise of sodium-glucose cotransporter 2 inhibitors in the management of nonalcoholic fatty liver disease. | 2019 | Details |
| A10323 | 31388096 | Int J Obes (Lond) | Circulating microbiota-derived metabolites: a "liquid biopsy? | 2019 | Details |
| A10324 | 31387736 | Lancet Gastroenterol Hepatol | Management of metabolic syndrome and cardiovascular risk after liver transplantation. | 2019 | Details |
| A10327 | 31387232 | Int J Environ Res Public Health | DNA Hydroxymethylation at the Interface of the Environment and Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10328 | 31387231 | Antioxidants (Basel) | Lycopene Modulates Pathophysiological Processes of Non-Alcoholic Fatty Liver Disease in Obese Rats. | 2019 | Details |
| A10332 | 31386565 | Am J Physiol Endocrinol Metab | Adipocyte-specific deletion of IL-6 does not attenuate obesity-induced weight gain or glucose intolerance in mice. | 2019 | Details |
| A10333 | 31386258 | Liver Int | Non-alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversion. | 2019 | Details |
| A10336 | 31384598 | Clin Nutr Res | Does Turmeric/curcumin Supplementation Change Anthropometric Indices in Patients with Non-alcoholic Fatty Liver Disease? A Systematic Review and Meta-analysis of Randomized Controlled Trials. | 2019 | Details |
| A10338 | 31384531 | Acta Pharm Sin B | Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters. | 2019 | Details |